Показати скорочений опис матеріалу

dc.contributor.author Benzar, I. M. en
dc.contributor.author Rebenkov, S. O. en
dc.contributor.author Levytskyi, A. F. en
dc.contributor.author Fedoniuk, L. Y. en
dc.contributor.author Fomina, L. V. en
dc.contributor.author Sas, L. M. en
dc.contributor.author Stravskyy, T. Y. en
dc.date.accessioned 2025-03-20T11:39:59Z
dc.date.available 2025-03-20T11:39:59Z
dc.date.issued 2020
dc.identifier.citation Newborns with kasabach-merritt phenomenon-associated kaposiform hemangioendothelioma: a report of 6 cases / I. M. Benzar, S. O. Rebenkov, A. F. Levytskyi [et al.] // Wiadomosci lekarskie. – 2020. – Vol. 73, № 8. – P. 1785–1789. en
dc.identifier.uri https://dspace.vnmu.edu.ua/123456789/8340 en
dc.description.abstract Combination of kaposiform hemangioendothelioma (KHE) and Kasabach-Merritt phenomenon (KMP) in newborn children is a life-threatening constellation. The purpose of the study is the choice of the diagnostic and treatment methods in these patients and evaluating the effectiveness of treatment using radiological methods of investigation. The study enrolled 6 newborn patients with KHE within a period 2013–2018. MRI (CT) performed to make the diagnosis and evaluate treatment response. Hypervascular mass accompanied by reticular lymphedema, hyper intensive in T2 WI; isointensive in T1 WI, intense contrast enhancement, heterogeneous diffusion restriction were unique MRI characteristics of KHE. The sustained remission was achieved with treatment by propranolol (n=2), vincristine (n=1), and their combination (n=3). en
dc.language.iso en en
dc.publisher Wiadomosci lekarskie en
dc.subject kaposiform hemangioendothelioma en
dc.subject Kasabach-Merritt phenomenon en
dc.subject newborns en
dc.subject thrombocytopenia en
dc.title Newborns with kasabach-merritt phenomenon-associated kaposiform hemangioendothelioma: a report of 6 cases en
dc.type Article en


Файли цього елементу

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу